TET2 c.695A>G ;(p.Q232R)

Variant ID: 4-106155794-A-G

NM_001127208.2(TET2):c.695A>G;(p.Q232R)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


TET2 missense variants in human neoplasia. A proposal of structural and functional classification.

Molecular Genetics & Genomic Medicine
Bussaglia, Elena E; Antón, Rosa R; Nomdedéu, Josep F JF; Fuentes-Prior, Pablo P
Publication Date: 2019-07

Variant appearance in text: TET2: 695A>G; Gln232Arg; rs202024319
PubMed Link: 31187595
Variant Present in the following documents:
View BVdb publication page



Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report.

Drug Design, Development And Therapy
Mao, Shiyu S; Zhang, Junfeng J; Guo, Yadong Y; Zhang, Ziwei Z; Wu, Yuan Y; Zhang, Wentao W; Wang, Longsheng L; Geng, Jiang J; Yan, Yang Y; Yao, Xudong X
Publication Date: 2019

Variant appearance in text: TET2: 695A>G; Gln232Arg
PubMed Link: 30666091
Variant Present in the following documents:
  • Main text
View BVdb publication page



Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified.

Haematologica
Ji, Meng-Meng MM; Huang, Yao-Hui YH; Huang, Jin-Yan JY; Wang, Zhao-Fu ZF; Fu, Di D; Liu, Han H; Liu, Feng F; Leboeuf, Christophe C; Wang, Li L; Ye, Jing J; Lu, Yi-Ming YM; Janin, Anne A; Cheng, Shu S; Zhao, Wei-Li WL
Publication Date: 2018-04

Variant appearance in text: TET2: Q232R
PubMed Link: 29305415
Variant Present in the following documents:
  • 2017.182444.Ji_SUPPL.pdf
View BVdb publication page